CNBC Investing Club: Cramer’s Morning Take on Costco 3/20/26

SPEAKER_1 (0:00)

Trading at Schwab is powered by Ameritrade, giving you even more specialized support than ever before, like access to the trade desk. Our team of passionate traders ready to tackle anything from the most complex trading questions to a simple strategy gut check. Need assistance? No problem. Get 24-7 professional answers and live help, and access support by phone, email, and in-platform chat. That's how Schwab is here for you, to help you trade brilliantly. Learn more at schwab.com/trading.

David Faber (0:28)

Thy ticket, Lady Jennifer of Coolidge.

Jim Cramer (0:31)

Well, many thanks, good sir.

SPEAKER_4 (0:33)

Heareth my Discover card.

SPEAKER_1 (0:36)

They accept Discover at Renaissance Fairs?

David Faber (0:38)

Yeah, they do here.

Jim Cramer (0:40)

Discover is accepted at the places I love to shop.

David Faber (0:42)

Getteth with the times.

SPEAKER_1 (0:45)

With the times?

SPEAKER_5 (0:46)

You're playing the lute.

David Faber (0:49)

Yeah, and it sounds pretty good, right?

SPEAKER_5 (0:51)

Discover is accepted at 99% of places that take credit cards nationwide. Based on the February 2025 Nielsen Report.

Jim Cramer (1:00)

Jim Cramer here to share a short preview of my take on the market from today's members-only CNBC Investing Club morning meeting. Join the club for full access to the morning meeting every day at 1020 a.m. Visit cnbc.com/morningtake to sign up today. That's one word, morning take. The president's got his eye on what we're looking at, okay?

And he has his eye, of course, on the Middle East. And what matters to me is that he does not like to see this market go down. Remember, that's what he always said about sleepy Joe Biden. I don't like to make fun of him. But this is an inflationary environment and that's what he has always criticized Biden on. He's not criticizing Biden on the right things. It's very strange. Biden really was against the big LNG projects and slow walked the okays. He should be mentioning that. I mean, I'm not trying to run his presidency, but he doesn't seem to... He seems to be off his domestic game. And I think that's what we're feeling.

David Faber (2:02)

Well, as the war continues on, we are always looking for companies and stocks that could have some benefit from it. We've highlighted a helium shortage, could be good for Lindy, as helium has been in oversupply and that could help their prices.

Jim Cramer (2:20)

And somebody upgraded, they keep upgrading APD, that's a second rate company versus ours.

David Faber (2:25)

But another one I was going to mention was when we historically see increases in prices at the pump, it's simply good for Costco because people go maybe the extra mile or two to get that lower price. And while they're at the gas station, they'll take a look in the store.

Jim Cramer (2:47)

I'm going to mention, this feels break out to me. I know that the last few numbers have been good and where they're selling things is very good. Remember, they don't make a lot of money on food. They try to sell food at a reasonable price. We were talking about how the herd may have to be thinned because, even Carl and I, because it's too expensive to feed them. Well, you know what? One of the areas that people go to is the meat section, which is very big for Costco. So I think that Costco is a winner.

I'm sorry, I'm looking, I'm possessed by how NVIDIA is now down 10 straight points from where it was on Monday. And that's just very disappointing.

David Faber (3:24)

Well, one more on Costco before we get to NVIDIA. Gordon Haskett put out some research this morning and they've seen it in the data that there's been a sharp inflection in traffic in the first week of March and that accelerated last week as well.

SPEAKER_4 (3:40)

All opinions expressed by Jim Cramer on this podcast and in connection with the CNBC Investing Club are solely Cramer's opinions and do not reflect the opinions of CNBC or its parent company or affiliates and may have been previously disseminated by Cramer on television, radio, internet or another medium. No specific outcome or profit is guaranteed in connection with your reliance upon or other use of the content from Cramer. The opinions offered in connection with this podcast and the CNBC Investing Club are not an attempt to induce any particular trading behavior, investment or strategy. To view the full CNBC Investing Club Disclaimer, please visit cnbc.com/investingclubdisclaimer.

SPEAKER_5 (4:12)

Snoring, gasping during sleep, feeling fatigued? Wake up to ZepBound Terzepatide, the first and only FDA approved prescription medicine for moderate to severe obstructive sleep apnea, OSA, and adults with obesity. ZepBound is an injectable prescription medicine that may help adults with moderate to severe obstructive sleep apnea, OSA, and obesity to improve their OSA. ZepBound should be used with a reduced calorie diet and increased physical activity.